{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:25:20Z","timestamp":1767857120332,"version":"3.49.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is often diagnosed at an unresectable stage without opportunities for curative therapy. Future liver remnant (FLR) insufficiency limits the range of patients who can undergo radical resection. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can ultimately achieve short-term hypertrophy of the FLR in patients with viral hepatitis-related fibrosis\/cirrhosis and R0 resection. However, the influence of immune checkpoint inhibitors (ICIs) on liver regeneration remains unknown. We report two patients diagnosed with Barcelona Clinic Liver Cancer (BCLC)-B stage hepatitis B virus (HBV)-related HCC who underwent pioneering ALPPS after immunotherapy without posthepatectomy liver failure (PHLF). ALPPS has been shown to be safe and feasible in patients with HCC who underwent immunotherapy previously for the first time and might provide an alternative salvage option for future conversion therapy of HCC.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1159885","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:30:46Z","timestamp":1683610246000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: The application of associating liver partition and portal vein ligation for staged hepatectomy in patients with hepatitis b virus-related hepatocellular carcinoma after undergoing treatment with an immune checkpoint inhibitor: a report of two cases"],"prefix":"10.3389","volume":"14","author":[{"given":"Cong","family":"Ning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanmo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000002942","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis b virus-related hepatocellular carcinoma: a single center study of 45 patients","volume":"271","author":"Wang","year":"2020","journal-title":"Ann Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/sla.0000000000001450","article-title":"Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry","volume":"262","author":"Schadde","year":"2015","journal-title":"Ann Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.21037\/hbsn-20-264","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative study","volume":"11","author":"Li","year":"2022","journal-title":"Hepatobil Surg Nutr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2016.07.029","article-title":"Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: complete-ALPPS versus partial-ALPPS","volume":"161","author":"Chan","year":"2017","journal-title":"Surgery"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi7083","article-title":"Resident kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy","volume":"6","author":"Siwicki","year":"2021","journal-title":"Sci Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.06.037","article-title":"T Cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model","volume":"75","author":"Llewellyn","year":"2021","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2020.05.012","article-title":"Liver regeneration and liver metastasis","volume":"71","author":"Riddiough","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(00)01583-9","article-title":"Standard liver volume in adults","volume":"32","author":"Urata","year":"2000","journal-title":"Transplant Proc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","article-title":"mRECIST for HCC: performance and novel refinements","volume":"72","author":"Llovet","year":"2020","journal-title":"J Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.21037\/atm-20-2420","article-title":"The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis b virus-related hepatocellular carcinoma","volume":"8","author":"Ke","year":"2020","journal-title":"Ann Transl Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-21-188","article-title":"Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy","volume":"10","author":"Yang","year":"2021","journal-title":"Hepatobil Surg Nutr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.sla.0000133123.11932.19","article-title":"Salvage surgery following downstaging of unresectable hepatocellular carcinoma","volume":"240","author":"Lau","year":"2004","journal-title":"Ann Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2018.10.014","article-title":"Future liver remnant hypertrophy after portal vein embolization is inversely correlated with intrahepatic tumor burden","volume":"30","author":"Takahashi","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1159\/000509081","article-title":"Mechanisms of immune-related complications in cancer patients treated with immune checkpoint inhibitors","volume":"106","author":"K\u00f6nig","year":"2021","journal-title":"Pharmacology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21597","article-title":"Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice","volume":"45","author":"Dong","year":"2007","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2021.2002068","article-title":"PD-1 blockade improves the anti-tumor potency of exhausted CD3(+)CD56(+) NKT-like cells in patients with primary hepatocellular carcinoma","volume":"10","author":"Tao","year":"2021","journal-title":"Oncoimmunology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000003433","article-title":"ALPPS versus portal vein embolization for hepatitis-related hepatocellular carcinoma: a changing paradigm in modulation of future liver remnant before major hepatectomy","volume":"273","author":"Chan","year":"2021","journal-title":"Ann Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.21037\/atm.2019.10.57","article-title":"ALPPS for hepatocarcinoma under cirrhosis: a feasible alternative to portal vein embolization","volume":"7","author":"Lopez-Lopez","year":"2019","journal-title":"Ann Transl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2015.12.027","article-title":"ALPPS: innovation for innovation\u2019s sake","volume":"159","author":"Belghiti","year":"2016","journal-title":"Surgery"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1159885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:30:49Z","timestamp":1683610249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1159885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2023.1159885"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1159885","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"1159885"}}